| 1 |
33146835 | Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer. | 2021 Jul |
1 |
| 2 |
33147611 | A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma. | 2021 Feb 8 |
3 |
| 3 |
33585350 | Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy. | 2021 Feb |
1 |
| 4 |
33610484 | Neutropenia Prevention in the Treatment of Post-docetaxel Metastatic, Castration-resistant Prostate Cancer With Cabazitaxel and Prednisone: A Multicenter, Open-label, Single-arm Phase IV Study. | 2021 Jun |
3 |
| 5 |
33860642 | Prevention of docetaxel-associated febrile neutropenia with primary granulocyte colony-stimulating factor in Chinese metastatic hormone-sensitive and castration-resistant prostate cancer patients. | 2021 Apr |
3 |
| 6 |
34870568 | Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy. | 2021 Dec 6 |
1 |
| 7 |
33203399 | A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. | 2020 Nov 17 |
1 |
| 8 |
30998754 | Early neutropenia on day 8 treated with adjuvant Docetaxel-based chemotherapy in early breast cancer patients: Putative mechanisms within the neutrophil pool system. | 2019 |
2 |
| 9 |
31814585 | Chemotherapy-induced febrile neutropenia: primary G-CSF prophylaxis indicated during docetaxel cycles. | 2019 Dec |
2 |
| 10 |
29948238 | Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. | 2018 Dec |
2 |
| 11 |
29963237 | Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer. | 2018 Jun 12 |
4 |
| 12 |
30206044 | Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L). | 2018 Nov |
1 |
| 13 |
30220167 | [The role of prophylactic use of pegylated recombinant human granulocyte colony-stimulating factor(PEG-rhG-CSF) in breast cancer receiving adjuvant chemotherapy]. | 2018 Sep 11 |
1 |
| 14 |
28264648 | A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. | 2017 Mar 6 |
1 |
| 15 |
26925666 | Safety Analysis of Adjuvant Chemotherapy with Docetaxel Administered with or without Anthracyclines to Early Stage Breast Cancer Patients: Combined Results from the Asia- Pacific Breast Initiatives I and II. | 2016 |
2 |
| 16 |
25791363 | Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies. | 2015 May |
3 |
| 17 |
26337685 | The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis. | 2015 Oct |
1 |
| 18 |
23371824 | Toxicity and quality of life of Korean breast cancer patients treated with docetaxel-containing chemotherapy without primary G-CSF prophylaxis. | 2014 Nov |
2 |
| 19 |
24595405 | Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres. | 2014 Aug |
2 |
| 20 |
24821366 | Efficacy and safety of early G-CSF administration in patients with head and neck cancer treated by docetaxel-cisplatin and 5-fluorouracil (DCF protocol): a retrospective study. | 2014 Oct |
1 |
| 21 |
22999386 | An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer. | 2013 Jan |
1 |
| 22 |
23686402 | Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review. | 2013 Oct |
1 |
| 23 |
24155641 | Chemotherapy (gemcitabine, docetaxel plus gemcitabine, doxorubicin, or trabectedin) in inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a clinical practice guideline. | 2013 Oct |
1 |
| 24 |
22993377 | Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study. | 2012 Sep |
1 |
| 25 |
23098625 | PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours. | 2012 Oct 25 |
1 |
| 26 |
20708854 | Preclinical and pilot clinical studies of docetaxel chemoradiation for Stage III non-small-cell lung cancer. | 2011 Aug 1 |
1 |
| 27 |
21550007 | Third-line or fourth-line chemotherapy in non-small-cell lung cancer patients with relatively good performance status. | 2011 May |
1 |
| 28 |
19773618 | [Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicin]. | 2009 |
2 |
| 29 |
19015070 | Phase II study of dose-dense doxorubicin and docetaxel as neoadjunvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer. | 2008 Nov |
2 |
| 30 |
17855189 | Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: a phase II study. | 2007 Aug |
1 |
| 31 |
17873305 | Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study. | 2007 |
1 |
| 32 |
17094396 | Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin. | 2006 Sep-Oct |
1 |
| 33 |
16020968 | Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients. | 2005 |
1 |
| 34 |
17523775 | Docetaxel as single-agent treatment in elderly patients with advanced breast cancer. | 2005 |
1 |
| 35 |
15033663 | A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer. | 2004 Apr |
1 |
| 36 |
15075667 | A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor. | 2004 Feb |
3 |
| 37 |
15222004 | Reducing the time interval between cycles using standard doses of docetaxel and lenogastrim support: a feasibility study. | 2004 Jul 1 |
3 |
| 38 |
12469168 | A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck. | 2003 Jan-Feb |
1 |
| 39 |
12538457 | Phase I and pharmacokinetic study of escalating dose of docetaxel administered with granulocyte colony-stimulating factor support in adult advanced solid tumors. | 2003 Jan |
4 |
| 40 |
12665678 | Phase 1 dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors. | 2003 |
1 |
| 41 |
12702535 | A phase I dose-escalation study of docetaxel with granulocyte colony-stimulating factor support in patients with solid tumours. | 2003 May |
4 |
| 42 |
12804178 | Phenotypic and immunologic characteristics of docetaxel-mobilized peripheral blood stem cells in mice. | 2003 Apr |
1 |
| 43 |
11852999 | Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer. | 2002 |
1 |
| 44 |
12367797 | Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale. | 2002 Oct |
1 |
| 45 |
12419756 | Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics. | 2002 Nov |
3 |
| 46 |
12425755 | Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial. | 2002 Oct |
1 |
| 47 |
11408509 | Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer. | 2001 Jun 15 |
1 |
| 48 |
11583191 | Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. | 2001 Aug |
1 |
| 49 |
10675076 | Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. | 2000 Jan 22 |
1 |
| 50 |
10810400 | Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature. | 2000 Mar-Apr |
1 |